This is important for choosing the right treatment
The pulse radiolysis studies demonstrated that DSePA-mediated radioprotection of in vitro models was due to its ability to directly scavenge the radiolytically generated hydroxyl and peroxyl radicals [82, 83, 85,86,87]
For patients who rely on peptide therapy for recovery, immune support, metabolic health, and longevity, this is significant news
Status Safety concerns listed 11 May 2026 Jurisdiction or evidence type United States / FDA Event FDA evaluation of BPC-157-related bulk drug substances finds insufficient evidence for nominated use and notes characterisation and safety gaps
When shots make sense (and when they don't) Injections are the right call in specific situations: confirmed severe deficiency, pernicious anemia (where intrinsic factor is absent), or documented malabsorption that has failed to respond to oral supplementation
Book a Consultation BPC-157 is believed to interact with the bodys natural healing pathways